Passionate about making healthcare more effective
We believe the current state of the US Health System is sub-par, but it doesn't need to be. Despite having the world's most renowned doctors and hospitals as well as enormous investment (twice as much per individual as any other country in the world), the US ranks 37th in healthcare efficacy according to the World Health Organization. We can do better simply by getting critical information to the right people at the right time and involving patients in their own care.
With our combined experience in both the business world and the healthcare system, we seek to bring open-source principles to the health information exchange. It’s not about lessening security, but about making existing data access more intuitive and effective. Our ultimate vision is to connect all the parties in the Health ecosystem safely and securely.
On a personal note, my mother, husband and I have gone years without proper diagnoses of chronic and acute illnesses that led to failing health and reduced quality of life. Through it all, we saw dozens of doctors at some of the best hospitals in the world. We all had private insurance, a rarity to be sure, but only one of us was covered for the majority of our costs. I am convinced that if all the doctors had had the same information, they could have diagnosed us more quickly. Furthermore, if we had been more informed ourselves, we would have researched better, found more support groups and gotten well faster.
While better connectivity alone cannot solve the nation’s healthcare problem, information is the beginning of change. We believe that by getting the information to the people who need it, we can start making a significant impact.
The Axial team has brought disruptive innovation to financial services and enterprise software. Healthcare is next.
CEO, brings 30 years of relevant experience growing companies using disruptive business models. Former COO and Director of Health IT Strategy of Red Hat, Ms. Rohde supervised revenue growth from $100 to $500 million. As CIO of UBS Investment Banking IT, she managed a $1 billion annual budget and 1,500 mission-critical systems. jrohde (at) axialexchange.com
VP Products and Marketing, formerly led the global ISV group for Red Hat Enterprise Linux and drove partnerships with SAP, IBM, HP and other global software partners. Mr. Mattox led the creation of Red Hat's open source ecosystem initiative, Red Hat Exchange, from concept to revenue. As Director of Product Management at Red Hat, Mr. Mattox was named co-inventor on 13 patent applications related to software. Formerly with MIT, idealab! and CitySearch, Mr. Mattox holds an MBA from Harvard Business School. mmattox (at) axialexchange.com
VP Operations and Finance, brings 15 years of experience in Corporate Finance and in the leadership of service and implementation businesses. Mr. Casey is a former Executive Vice President of UBS Investment Banking IT and Vice President of Equity Capital Markets, Donaldson, Lufkin & Jenrette Securities Corporation. He holds an MBA from Wharton Business School, majoring in Finance with emphasis on Healthcare. jcasey (at) axialexchange.com
VP Business Development, has over 25 years in technology and has held senior leadership roles in strategic planning, product and corporate marketing, and business development at Nortel, Fujitsu and Sumitomo. He has held key executive positions at start-ups Videoserver (IPO) & Aegis Technologies (sold to New York Life) and has over 15 years of exposure in many standards-setting bodies including the ITU, IETF, ATM forum, DAVIC, DSL Forum and the IEEE. Mr. Ragusa holds a BS from Embry Riddle Aeronautical University and an ME from Western Carolina University. mragusa (at) axialexchange.com
Board of Directors
Stephen Bloch, M.D.
General Partner, Canaan Partners. Having been an entrepreneur and practicing physician, Dr. Stephen Bloch knows firsthand how to navigate the opportunities and challenges of building successful healthcare companies. He draws on his experience in medicine, government and business to invest in areas of healthcare that promise to change how medicine is practiced. Stephen received his medical training at Massachusetts General Hospital/Harvard Medical School (radiology) and Lenox Hill Hospital/Cornell Medical School (internal medicine). He earned his medical degree from the University of Rochester, a MA in the history of science and public policy from Harvard University and an AB degree from Dartmouth College. Stephen was honored as a Ewing Marion Kauffman Fellow in 2002, an educational program that develops future leaders of the global venture capital industry.
General Partner, IDEA Fund Partners, holds responsibilities for finance and investor relations functions, in addition to serving as a key member of the investment team and advisor to portfolio companies. John also serves as the Chief Financial Officer of NC IDEA and an advisor to its grants program, playing a key role in the company selection and mentoring process. Working in the technology sector since 1994, John has held various operational roles and was involved in the spin-off of four companies from MCNC, including the formation and ultimate sale of Cronos Integrated Microsystems to JDS Uniphase for $665 million in 2000. John received a B.A. in International Relations from Michigan State University and an M.B.A. from the University of North Carolina at Chapel Hill.
Wilmington Investor Network, a healthcare information technology executive for nearly three decades, most recently served as AVP for McKesson’s Advanced Diagnostic Management business unit. In 1984, he founded MegaSource, a pharmacy information system for hospitals. After selling MegaSource to Cerner in 1993, he became Cerner’s Vice President & Pharmacy Product Line Executive, a position he held until 1995. In 1996, he co-founded CareInsite (CareAgents), serving as Senior Vice President responsible for PBM and Physician Connectivity. From 2002 until 2005, he joined Eclipsys as regional president, where he created a new business intelligence product line. From 2003 until the sale of the company to LabCorp in 2010, he served as Senior Vice President of Correlagen Diagnostics. Mr. Carney received his degree in mechanical engineering and his MBA from the University of Michigan.